E-cigarette Nicotine Delivery: Data and Learnings from Pharmacokinetic Studies
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Fearon (2017)
Monitoring harm perceptions of smokeless tobacco products among U.S. adults: Health Information National Trends Survey 2012, 2014, 2015
Population Clinical
Perception Of Risk
Comparison With
Tobacco Or Other
Nicotine Products
Feirman (2018)
Computational transport, phase change and deposition analysis of inhaled multicomponent droplet–vapor mixtures in an idealized human upper lung model
Non-clinical
Respiratory Toxicity
In Vitro
Feng (2016)
Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies
Population Clinical
Consumer Use
Youth Use & Appeal
Ferkol (2018)
Experimentation with e-cigarettes as a smoking cessation aid: a cross-sectional study in 28 European Union member states
Population Clinical
Cessation
Tobacco Cessation
Filippidis (2016)
Two-year trends and predictors of e-cigarette use in 27 European Union member states
Population Clinical
Consumer Use
Factors
Influencing
Patterns Of Use
Filippidis (2017)
Secondhand smoke exposure at home among middle and high school students in the United States – does the type of tobacco product matter?
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Fischer and Kraemer (2017)
Cohort study of electronic cigarette use: safety and effectiveness after 4 years of follow-up
Population Clinical
Likelihood Of Use
Current Smokers
Switching From
Tobacco Products
To Ends
Flacco (2019)
Respiratory bronchiolitis‐associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy
Non-clinical
Respiratory Toxicity
In Vivo
Flower (2017)
Electronic cigarette power affects count concentration and particle size distribution of vaping aerosol
Individual Clinical
User Topography
Floyd (2018)